Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02133196
Title T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung non-small cell carcinoma

Therapies

Aldesleukin + Cyclophosphamide + Fludarabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.